Stryker (Germany) Performance
| SYK Stock | EUR 319.30 0.80 0.25% |
The entity has a beta of 0.38, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Stryker's returns are expected to increase less than the market. However, during the bear market, the loss of holding Stryker is expected to be smaller as well. At this point, Stryker has a negative expected return of -0.0187%. Please make sure to validate Stryker's daily balance of power, market facilitation index, and the relationship between the kurtosis and day median price , to decide if Stryker performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Stryker has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Stryker is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 2.9 B | |
| Free Cash Flow | 2 B |
Stryker |
Stryker Relative Risk vs. Return Landscape
If you would invest 32,541 in Stryker on June 20, 2025 and sell it today you would lose (611.00) from holding Stryker or give up 1.88% of portfolio value over 90 days. Stryker is currently producing negative expected returns and takes up 1.4457% volatility of returns over 90 trading days. Put another way, 12% of traded stocks are less volatile than Stryker, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Stryker Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stryker's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Stryker, and traders can use it to determine the average amount a Stryker's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.013
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SYK |
Estimated Market Risk
| 1.45 actual daily | 13 87% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Stryker is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stryker by adding Stryker to a well-diversified portfolio.
Stryker Fundamentals Growth
Stryker Stock prices reflect investors' perceptions of the future prospects and financial health of Stryker, and Stryker fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Stryker Stock performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0618 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 101.82 B | |||
| Shares Outstanding | 378.83 M | |||
| Price To Earning | 20.44 X | |||
| Price To Book | 5.77 X | |||
| Price To Sales | 4.90 X | |||
| Revenue | 18.45 B | |||
| EBITDA | 4.04 B | |||
| Cash And Equivalents | 1.84 B | |||
| Cash Per Share | 4.92 X | |||
| Total Debt | 11.86 B | |||
| Debt To Equity | 74.20 % | |||
| Book Value Per Share | 43.88 X | |||
| Cash Flow From Operations | 2.62 B | |||
| Earnings Per Share | 5.83 X | |||
| Total Asset | 36.88 B | |||
About Stryker Performance
By analyzing Stryker's fundamental ratios, stakeholders can gain valuable insights into Stryker's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Stryker has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Stryker has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Stryker Corporation operates as a medical technology company. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan. STRYKER CORP operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 36000 people.Things to note about Stryker performance evaluation
Checking the ongoing alerts about Stryker for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Stryker help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Stryker generated a negative expected return over the last 90 days | |
| Stryker has accumulated €11.86 Billion in debt which can lead to volatile earnings | |
| Over 80.0% of the company shares are owned by institutional investors |
- Analyzing Stryker's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Stryker's stock is overvalued or undervalued compared to its peers.
- Examining Stryker's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Stryker's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Stryker's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Stryker's stock. These opinions can provide insight into Stryker's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Stryker Stock analysis
When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |